
### [NCIT:C91255](http://purl.obolibrary.org/obo/NCIT_C91255)
**Label:** Nasal Cavity and Paranasal Sinus Cancer by AJCC v7 Stage

**Subclasses:** [NCIT:C6009](http://purl.obolibrary.org/obo/NCIT_C6009) (Stage IV Paranasal Sinus Cancer AJCC v7), [NCIT:C6006](http://purl.obolibrary.org/obo/NCIT_C6006) (Stage I Paranasal Sinus Cancer), [NCIT:C6008](http://purl.obolibrary.org/obo/NCIT_C6008) (Stage III Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C6007](http://purl.obolibrary.org/obo/NCIT_C6007) (Stage II Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C4589](http://purl.obolibrary.org/obo/NCIT_C4589) (Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8), [NCIT:C6013](http://purl.obolibrary.org/obo/NCIT_C6013) (Stage I Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C6012](http://purl.obolibrary.org/obo/NCIT_C6012) (Stage II Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C6011](http://purl.obolibrary.org/obo/NCIT_C6011) (Stage III Nasal Cavity Cancer AJCC v6 and v7), [NCIT:C115073](http://purl.obolibrary.org/obo/NCIT_C115073) (Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7), [NCIT:C6010](http://purl.obolibrary.org/obo/NCIT_C6010) (Stage IV Nasal Cavity Carcinoma AJCC v7), [NCIT:C115072](http://purl.obolibrary.org/obo/NCIT_C115072) (Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C115071](http://purl.obolibrary.org/obo/NCIT_C115071) (Stage II Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C87498](http://purl.obolibrary.org/obo/NCIT_C87498) (Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8), [NCIT:C94768](http://purl.obolibrary.org/obo/NCIT_C94768) (Stage 0 Paranasal Sinus Cancer AJCC v6, v7, and v8), [NCIT:C67556](http://purl.obolibrary.org/obo/NCIT_C67556) (Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C115070](http://purl.obolibrary.org/obo/NCIT_C115070) (Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C67554](http://purl.obolibrary.org/obo/NCIT_C67554) (Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C67555](http://purl.obolibrary.org/obo/NCIT_C67555) (Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7), [NCIT:C89117](http://purl.obolibrary.org/obo/NCIT_C89117) (Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7), 

**Class expressions from DL-Learner:**

- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 54.17%
- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4021](http://purl.obolibrary.org/obo/NCIT_C4021) (Chondroblastic Osteosarcoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40209](http://purl.obolibrary.org/obo/NCIT_C40209) (Cervical Glandular Dysplasia))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40208](http://purl.obolibrary.org/obo/NCIT_C40208) (Cervical Villoglandular Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40206](http://purl.obolibrary.org/obo/NCIT_C40206) (Cervical Mucinous Adenocarcinoma, Minimal Deviation Type))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40205](http://purl.obolibrary.org/obo/NCIT_C40205) (Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4020](http://purl.obolibrary.org/obo/NCIT_C4020) (Fibroblastic Osteosarcoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma))) 39.52%


